Sequelae, Inc. — Form D
Sequelae, Inc. of MINNEAPOLIS, MN, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-12. The offering totals $60.0M, of which $60.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2024-04-12
- Form: D
- Accession: 0002019160-24-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $60.0M
- Amount sold: $60.0M
- Investors: 7
- Date of first sale: 2023-04-18
- Revenue range: Decline to Disclose
- SEC file number: 021-510405
Issuer
- Name: Sequelae, Inc.
- CIK: 0002019160
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 80 S 8TH ST #3100, MINNEAPOLIS, MN, 55402
- Phone: 763-442-7383
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Mark Pollmann | Executive Officer | Brooklyn Park, MN |
| Albert Zimmerli | Director | Minneapolis, MN |
| Rushika Fernandopulle | Director | Minneapolis, MN |
| Sara Taylor | Executive Officer | Minneapolis, MN |
| Mike Christy | Executive Officer | Minneapolis, MN |
| Gregory Johnson | Executive Officer | Vancouver, A1 |
| Amy Schulman | Director | Cambridge, MA |
| Ken Ehlert | Director | Minneapolis, MN |
| Ken Ehlert | Executive Officer | Minneapolis, MN |
| David Wichmann | Director | Minneapolis, MN |
| Mark Briesacher | Executive Officer | Minneapolis, MN |
| David Wichman | Director | Minneapolis, MN |
| Shiraz Fagan | Executive Officer | Minneapolis, MN |
| Mark Pollman | Executive Officer | Minneapolis, MN |
Other filings by this issuer (2)
More